Merck & Co. Collaborates with Orion to Develop and Commercialise ODM-208 for US$290 M
By Ashish Tripathi
Pharma Deals Review: Vol 2022 Issue 7 (Table of Contents)
Published: 28 Jul-2022
DOI: 10.3833/pdr.v2022.i7.2708 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In a bid to bolster its prostate cancer pipeline, Merck &Co...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018